Articles with public access mandates - Nicholas ChiorazziLearn more
Not available anywhere: 8
Review
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study
P Baliakas, A Hadzidimitriou, LA Sutton, E Minga, A Agathangelidis, ...
The lancet haematology 1 (2), e74-e84, 2014
Mandates: US National Institutes of Health, Swedish Research Council, Government of Italy
Review
Chronic lymphocytic leukemia with mutated IGHV4-34 receptors: shared and distinct immunogenetic features and clinical outcomes
A Xochelli, P Baliakas, I Kavakiotis, A Agathangelidis, LA Sutton, E Minga, ...
Clinical Cancer Research 23 (17), 5292-5301, 2017
Mandates: Swedish Research Council, European Commission, Government of Italy
Review
Murine genetically engineered and human xenograft models of chronic lymphocytic leukemia
SS Chen, N Chiorazzi
Seminars in hematology 51 (3), 188-205, 2014
Mandates: US National Institutes of Health
Review
CXCL13 plasma levels function as a biomarker for disease activity in patients with chronic lymphocytic leukemia
M Sivina, L Xiao, E Kim, A Vaca, SS Chen, MJ Keating, A Ferrajoli, ...
Leukemia 35 (6), 1610-1620, 2021
Mandates: US National Institutes of Health
Review
Chronic lymphocytic leukemia immunoglobulins display bacterial reactivity that converges and diverges from auto-/poly-reactivity and IGHV mutation status
K Hatzi, R Catera, CM Atanasio, VA Fischetti, SL Allen, JE Kolitz, KR Rai, ...
Clinical immunology 172, 44-51, 2016
Mandates: US National Institutes of Health
Review
Inhibition of reactive oxygen species limits expansion of chronic lymphocytic leukemia cells
B Yigit, N Wang, SS Chen, N Chiorazzi, C Terhorst
Leukemia 31 (10), 2273-2276, 2017
Mandates: US National Institutes of Health
Review
Origin and nature of chronic lymphocytic leukemia B cells
N Chiorazzi, M Ferrarini
Chronic Lymphocytic Leukemia, 17-34, 2008
Mandates: US National Institutes of Health
Review
B-cell chronic lymphocytic leukemia/lymphoma
PEM Patten, CC Chu, N Chiorazzi
Future Medicine Ltd, 2013
Mandates: US National Institutes of Health
Available somewhere: 105
Review
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
M Hallek, BD Cheson, D Catovsky, F Caligaris-Cappio, G Dighiero, ...
Blood, The Journal of the American Society of Hematology 131 (25), 2745-2760, 2018
Mandates: German Research Foundation
Review
Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies
A Agathangelidis, N Darzentas, A Hadzidimitriou, X Brochet, F Murray, ...
Blood, The Journal of the American Society of Hematology 119 (19), 4467-4475, 2012
Mandates: US National Institutes of Health, Swedish Research Council
Review
B cell receptor signaling in chronic lymphocytic leukemia
JA Burger, N Chiorazzi
Trends in immunology 34 (12), 592-601, 2013
Mandates: US National Institutes of Health
Review
Cellular origin (s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities
N Chiorazzi, M Ferrarini
Blood, The Journal of the American Society of Hematology 117 (6), 1781-1791, 2011
Mandates: US National Institutes of Health
Review
CD38 and chronic lymphocytic leukemia: a decade later
F Malavasi, S Deaglio, R Damle, G Cutrona, M Ferrarini, N Chiorazzi
Blood, The Journal of the American Society of Hematology 118 (13), 3470-3478, 2011
Mandates: US National Institutes of Health
Review
Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation
R Catera, GJ Silverman, K Hatzi, T Seiler, S Didier, L Zhang, M Hervé, ...
Molecular medicine 14, 665-674, 2008
Mandates: US National Institutes of Health
Review
Anti-CD20/CD3 T cell–dependent bispecific antibody for the treatment of B cell malignancies
LL Sun, D Ellerman, M Mathieu, M Hristopoulos, X Chen, Y Li, X Yan, ...
Science translational medicine 7 (287), 287ra70-287ra70, 2015
Mandates: US National Institutes of Health
Review
Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA
CC Chu, R Catera, K Hatzi, XJ Yan, L Zhang, XB Wang, HM Fales, ...
Blood, The Journal of the American Society of Hematology 112 (13), 5122-5129, 2008
Mandates: US National Institutes of Health
Review
Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin
CC Chu, R Catera, L Zhang, S Didier, BM Agagnina, RN Damle, ...
Blood, The Journal of the American Society of Hematology 115 (19), 3907-3915, 2010
Mandates: US National Institutes of Health
Review
Intraclonal complexity in chronic lymphocytic leukemia: fractions enriched in recently born/divided and older/quiescent cells
C Calissano, RN Damle, S Marsilio, XJ Yan, S Yancopoulos, G Hayes, ...
Molecular medicine 17, 1374-1382, 2011
Mandates: US National Institutes of Health
Review
BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia
SS Chen, BY Chang, S Chang, T Tong, S Ham, B Sherry, JA Burger, ...
Leukemia 30 (4), 833-843, 2016
Mandates: US National Institutes of Health
Review
In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia
C Calissano, RN Damle, G Hayes, EJ Murphy, MK Hellerstein, C Moreno, ...
Blood, The Journal of the American Society of Hematology 114 (23), 4832-4842, 2009
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program